The Gordon Research Seminar on Antibody Biology and Engineering is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.
The focus of the 2018 "Antibody Biology and Engineering" GRS is on biological processes that promote or limit antibody responses against tumors, foreign pathogens, and self-antigens, and how this knowledge is utilized to engineer next-generation antibodies to treat human diseases. The seminar will combine many aspects of antibody research with a particular focus on understanding and manipulating immune responses using natural and synthetic antibodies. Topics will span basic antibody biology, structure, function and diversity, through engineering approaches and clinical applications of antibodies as therapeutics. By intersecting industrial and academic investigators, this GRS will provide a platform to initiate fruitful collaborations aiming to design the next generation of antibody therapeutics to treat inflammatory and neurological diseases, infection, and cancer.
The seminar will feature approximately 10 talks and 2 poster sessions. All attendees are expected to actively participate in the GRS, either by giving an oral presentation or presenting a poster. Therefore, all applications must include an abstract.
The seminar chair will select speakers from abstracts submitted by December 24, 2017. Those applicants who are not chosen for talks and those who apply after the deadline to be considered for an oral presentation will be expected to present a poster. In order to participate, you must submit an application by the date indicated in the Application Information section above.